Literature DB >> 25587672

Gender differences in treatment retention among individuals with co-occurring substance abuse and mental health disorders.

Sam Choi1, Susie M Adams, Siobhan A Morse, Sam MacMaster.   

Abstract

BACKGROUND: A significant number of individuals with co-occurring substance abuse and mental health disorders do not engage, stay, and/or complete residential treatment. Although prior research indicates that women and men differ in their substance abuse treatment experiences, our knowledge of individuals with co-occurring substance abuse and mental health disorders as well as those attending private residential treatment is limited.
OBJECTIVES: The purpose of this study is to examine gender differences on treatment retention for individuals with co-occurring substance abuse and mental health disorders who participate in private residential treatment.
METHODS: The participants were 1,317 individuals (539 women and 778 men) with co-occurring substance abuse and mental health disorders receiving treatment at three private residential treatment centers. Bivariate analyses, life tables, and Cox regression (survival analyses) were utilized to examine gender effects on treatment retention, and identify factors that predict treatment retention for men and women.
RESULTS: This study found that women with co-occurring disorders were more likely to stay longer in treatment when compared to men. The findings indicate the factors influencing length of stay differ for each gender, and include: type of substance used prior to admission; Addiction Severity Index Composite scores; and Readiness to Change/URICA scores. Age at admission was a factor for men only. CONCLUSIONS/IMPORTANCE: These findings can be incorporated to develop and initiate program interventions to minimize early attrition and increase overall retention in private residential treatment for individuals with co-occurring substance use and mental health disorders.

Entities:  

Keywords:  co-occurring disorders; dual diagnosis; gender differences; predictors; residential treatment; retention; substance abuse and mental health disorder

Mesh:

Year:  2015        PMID: 25587672     DOI: 10.3109/10826084.2014.997828

Source DB:  PubMed          Journal:  Subst Use Misuse        ISSN: 1082-6084            Impact factor:   2.164


  18 in total

1.  Factors associated with Healthcare Effectiveness Data and Information Set (HEDIS) alcohol and other drug measure performance in 2014-2015.

Authors:  Constance Weisner; Cynthia I Campbell; Andrea Altschuler; Bobbi Jo H Yarborough; Gwen T Lapham; Ingrid A Binswanger; Rulin C Hechter; Brian K Ahmedani; Irina V Haller; Stacy A Sterling; Dennis McCarty; Derek D Satre; Andrea H Kline-Simon
Journal:  Subst Abus       Date:  2019-01-24       Impact factor: 3.716

2.  Co-Occurring Disorders: A Challenge for Mexican Community-Based Residential Care Facilities for Substance Use.

Authors:  Rodrigo Marín-Navarrete; María Elena Medina-Mora; Viviana E Horigian; Ihsan M Salloum; Luis Villalobos-Gallegos; José Fernández-Mondragón
Journal:  J Dual Diagn       Date:  2016-08-05

3.  Does change in readiness influence retention among African American women and men in substance abuse treatment?

Authors:  LaTrice Montgomery; A Kathleen Burlew; Jeffrey E Korte
Journal:  J Ethn Subst Abuse       Date:  2017-04-03       Impact factor: 1.507

4.  Contingency management treatments are equally efficacious for both sexes in intensive outpatient settings.

Authors:  Carla J Rash; Nancy M Petry
Journal:  Exp Clin Psychopharmacol       Date:  2015-07-13       Impact factor: 3.157

5.  Demographic and clinical profile of women receiving inpatient treatment at a deaddiction unit of a psychiatric hospital in India: Five years' observation.

Authors:  Sourav Khanra; Ujjwal Singh; Sanjay Kumar Munda; Basudeb Das
Journal:  Ind Psychiatry J       Date:  2022-02-17

Review 6.  Music therapy for people with substance use disorders.

Authors:  Claire Ghetti; Xi-Jing Chen; Annette K Brenner; Laurien G Hakvoort; Lars Lien; Jorg Fachner; Christian Gold
Journal:  Cochrane Database Syst Rev       Date:  2022-05-09

7.  The association of psychiatric comorbidity with treatment completion among clients admitted to substance use treatment programs in a U.S. national sample.

Authors:  Noa Krawczyk; Kenneth A Feder; Brendan Saloner; Rosa M Crum; Marc Kealhofer; Ramin Mojtabai
Journal:  Drug Alcohol Depend       Date:  2017-04-19       Impact factor: 4.492

8.  Patient characteristics associated with treatment initiation and engagement among individuals diagnosed with alcohol and other drug use disorders in emergency department and primary care settings.

Authors:  Andrea H Kline-Simon; Scott P Stumbo; Cynthia I Campbell; Ingrid A Binswanger; Constance Weisner; Irina V Haller; Rulin C Hechter; Brian K Ahmedani; Gwen T Lapham; Amy M Loree; Stacy A Sterling; Bobbi Jo H Yarborough
Journal:  Subst Abus       Date:  2019-01-31       Impact factor: 3.716

9.  Psychiatric comorbidity and Healthcare Effectiveness Data and Information Set (HEDIS) measures of alcohol and other drug treatment initiation and engagement across 7 health care systems.

Authors:  Amy M Loree; Hsueh-Han Yeh; Derek D Satre; Andrea H Kline-Simon; Bobbi Jo H Yarborough; Irina V Haller; Cynthia I Campbell; Gwen T Lapham; Rulin C Hechter; Ingrid A Binswanger; Constance Weisner; Brian K Ahmedani
Journal:  Subst Abus       Date:  2019-01-25       Impact factor: 3.716

10.  Examination of referral source and discharge outcomes among women in residential substance use disorder treatment.

Authors:  Dean Rivera; Donna Dueker; Mariana Sanchez; Hortensia Amaro
Journal:  J Subst Abuse Treat       Date:  2021-02-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.